Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Clinical trial NCT06906081 · RECRUITING

Trial details

NCT number: NCT06906081
Sponsor: Peter Rossing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiovascular Autonomic Neuropathy Type 2 Diabetes Diabetic Neuropathies

Start date: 2025-05-02
Primary completion: 2028-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.